2011
DOI: 10.1089/ars.2011.4170
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Mitochondrial Respiration and Rapid Depletion of Mitochondrial Glutathione by β-Phenethyl Isothiocyanate: Mechanisms for Anti-Leukemia Activity

Abstract: Although PEITC is a reactive compound and might have multiple mechanisms of action, we showed that a rapid depletion of GSH and inhibition of mitochondrial respiration are two important early events that induced synergistic cytotoxicity in leukemia cells. These findings not only suggest that PEITC is a promising compound for potential use in leukemia treatment, but also provide a basis for developing new therapeutic strategies to effectively kill leukemia cells by using a novel combination to modulate ROS and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
55
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 71 publications
(61 citation statements)
references
References 47 publications
6
55
0
Order By: Relevance
“…Given the role of GSH in the reduction of H 2 O 2 and the oxidation of sulfhydryl group, it is believed that GSH depletion will cause toxicity via accumulation of H 2 O 2 and oxidized proteins (6). It has been previously suggested that electrophilic small molecules such as buthionine sulfoximine (BSO), piperlongumine (PL), and phenethyl isothiocyanate (PEITC) convey at least part of their toxicity via this mechanism (9,16,39,49,51,56), and all of these drugs have been shown to be selectively toxic to certain in vitro and in vivo tumor models (1,5,13,39). Incubation of tumor cells with piperlongumine and PEITC results in depletion of GSH and elevation of fluorescence from dichloro-dihydro-fluorescein diacetate (DCFH-DA), a cell permeable dye that exhibits increasing fluorescence intensity upon oxidation (9,39,49,56).…”
Section: Innovationmentioning
confidence: 99%
See 1 more Smart Citation
“…Given the role of GSH in the reduction of H 2 O 2 and the oxidation of sulfhydryl group, it is believed that GSH depletion will cause toxicity via accumulation of H 2 O 2 and oxidized proteins (6). It has been previously suggested that electrophilic small molecules such as buthionine sulfoximine (BSO), piperlongumine (PL), and phenethyl isothiocyanate (PEITC) convey at least part of their toxicity via this mechanism (9,16,39,49,51,56), and all of these drugs have been shown to be selectively toxic to certain in vitro and in vivo tumor models (1,5,13,39). Incubation of tumor cells with piperlongumine and PEITC results in depletion of GSH and elevation of fluorescence from dichloro-dihydro-fluorescein diacetate (DCFH-DA), a cell permeable dye that exhibits increasing fluorescence intensity upon oxidation (9,39,49,56).…”
Section: Innovationmentioning
confidence: 99%
“…One of the mechanisms of piperlongumine and PEITC toxicity suggested by previous studies is the depletion of the total GSH level and the subsequent increase in oxidative stress (5,9,39,49,56). We used a specific, small-molecule inhibitor of GSH synthesis, BSO, as a control for determining whether the level of depletion in the two compounds is an important contributor to tumor inhibition (57).…”
Section: Differential Response Of Hela and A549 Cells To Piperlongumimentioning
confidence: 99%
“…b-Phenylethyl isothiocyanate (PEITC), a natural compound found in cruciferous vegetables, depletes GSH and selectively kills cancer cells while sparing healthy cells (14)(15)(16)(17). Given the fact that stimulation of ROS is generated by gemcitabine in PDAC cells, we hypothesized that the cells increase cellular GSH to prevent oxidative damage and that PEITC enhances the effect of gemcitabine-induced ROS through the redox modulation.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, there are data supporting the beneficial effects of targeting selected TME parameters, including tumor hypoxia (22,52,54,71), acidosis (4,35,36,60,61,68) (see Fig. 4), redox (10,57), and GSH content (11,44,56). A combination therapy aimed to normalize several of these interrelated TME parameters may provide further therapeutic advantages.…”
Section: Resultsmentioning
confidence: 98%